Use of Melatonin for Preventing POCD in Transurethral Prostate Resection Under Spinal Anesthesia
Melatonin, Cognitive Dysfunction, Postoperative Complications
About this trial
This is an interventional prevention trial for Melatonin focused on measuring Melatonin, Cognitive Dysfunction
Eligibility Criteria
Inclusion Criteria:
patients over 60 years who underwent elective surgery for transurethral prostate ressection under spinal anesthesia.
MME > 18 (for those who had less than 4 years of formal education ) or MME > 23 (for those with 4 or more years of formal education)
Exclusion Criteria:
MME < 18 (for those who had less than 4 years of formal eduaction) or 23 (for those with 4 years or more of formal eduacation); History of cancer, brain disease, seizure, Parkinson, dementia, hallucination or any disorder that affects cognition before the surgery.
Lack of proficiency in portuguese mild or severe hearing loss or blindness.
Sites / Locations
- Hospital das ClinicasRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
melatonin group
placebo group
for the melatonin group, 10 mg of melatonin will be taken per os in the evening before the surgery and in the immediate postoperative night and the first and second postoperative days.
For the placebo group, placebo will be administered per os in the evening before the surgery and in the immediate postoperative night and the first and second postoperative days.